SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $344,000 | -29.1% | 14,500 | -46.3% | 0.00% | -57.1% |
| Q1 2020 | $485,000 | +54.0% | 27,000 | +103.0% | 0.01% | +75.0% |
| Q4 2019 | $315,000 | +584.8% | 13,300 | +680.1% | 0.00% | +300.0% |
| Q3 2019 | $46,000 | -17.9% | 1,705 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $56,000 | -5.1% | 1,705 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $59,000 | +5.4% | 1,705 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $56,000 | -34.1% | 1,705 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $85,000 | +8400.0% | 1,705 | +2335.7% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | -92.3% | 70 | -93.5% | 0.00% | – |
| Q1 2015 | $13,000 | -96.6% | 1,070 | -97.6% | 0.00% | -100.0% |
| Q4 2014 | $385,000 | +39.0% | 45,265 | +43.8% | 0.01% | +16.7% |
| Q3 2014 | $277,000 | -22.8% | 31,467 | 0.0% | 0.01% | -25.0% |
| Q2 2014 | $359,000 | -35.0% | 31,467 | -28.7% | 0.01% | -27.3% |
| Q1 2014 | $552,000 | +145.3% | 44,108 | +75.8% | 0.01% | +120.0% |
| Q4 2013 | $225,000 | -51.6% | 25,087 | -57.5% | 0.01% | -50.0% |
| Q3 2013 | $465,000 | -48.2% | 59,052 | -55.9% | 0.01% | -56.5% |
| Q2 2013 | $897,000 | – | 133,804 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |